Cargando…
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of a Novel Inhaled Biologic Therapeutic in Adults with Respiratory Distress Secondary to COVID-19 Infection
INTRODUCTION: Inhaled therapeutics may act to directly target and attenuate lung inflammation due to COVID-19. An inhalation form of a novel biologic drug, AMP5A, is being developed as an immunomodulatory agent to treat dysregulated immune responses and is being studied in hospitalized patients to t...
Autores principales: | Roshon, Michael, Lemos-Filho, Luciano, Cherevka, Holli, Goldberg, Laura, Salottolo, Kristin, Bar-Or, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590808/ https://www.ncbi.nlm.nih.gov/pubmed/34775578 http://dx.doi.org/10.1007/s40121-021-00562-z |
Ejemplares similares
-
Intra-articular injection of the anti-inflammatory compound LMWF-5A in adults with severe osteoarthritis: a double-blind prospective randomized controlled multi-center safety and efficacy trial
por: Salottolo, Kristin, et al.
Publicado: (2018) -
Acute Respiratory Distress Due to Methane Inhalation
por: Jo, Jun Yeon, et al.
Publicado: (2013) -
Does time to surgery for traumatic hip fracture impact the efficacy of fascia iliaca blocks? A brief report
por: Akinola, Kerrick, et al.
Publicado: (2022) -
Respiratory Distress Secondary to Esophageal Foreign Body. A Case Report
por: Urkin, Jacob, et al.
Publicado: (2006) -
Validity between self-report and biochemical testing of cannabis and drugs among patients with traumatic injury: brief report
por: Salottolo, Kristin, et al.
Publicado: (2022)